RSV: The Disease and Pipeline Vaccines
UPDATED August 27, 2023 Several highly concerning RSV products have now been licensed and approved for use in our most vulnerable populations: pregnant women, newborns and those age 60 and over. Prepare to be bombarded by marketing messages and pressure from doctors and nurses, who will be unaware of the concerns raised in the clinical …